This revision of the 2005 British Association for Psychopharmacology guidelines for the
evidence-based pharmacological treatment of anxiety disorders provides an update on key …

These British Association for Psychopharmacology guidelines cover the range and aims of
treatment for anxiety disorders. They are based explicitly on the available evidence and are …

Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

In this report, recommendations for the pharmacological treatment of anxiety and obsessive-
compulsive disorders are presented, based on available randomized, placebo-or …

Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care,
although they can be managed effectively by general practitioners. Methods. This paper is a …

Aim This is the third version of the guideline of the World Federation of Societies of
Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety …

A consensus group consisting of 36 experts representing 20 leading German specialist
societies and patient self-help organizations developed evidence-based recommendations …

Given the enormous contribution of anxiety disorders to the burden of disease, it is key to
optimize their prevention and treatment. In this critical review we assess advances in the …

Background Anxiety disorders (panic disorder/agoraphobia, generalized anxiety disorder,
social phobia, and specific phobias) are the most common mental illnesses. For example …